Diagnostic Biosystems (DBS), a specialty immunohistochemistry (IHC) reagent company, announces the availability of antibodies and reagents for clinical IHC use in the US. Diagnostic BioSystems is an FDA registered, CDPH medical device manufacturer, and is ISO 9001:2000 and cGMP certified.
Founded in 1994 as a life science supplier of novel, high quality IHC products in over 45 countries, DBS introduces a complete selection of IVD labeled staining reagents suitable for manual and automated staining platforms. DBS offers IVD labeled concentrated and pre-diluted ready-to-use primary antibodies and immunostaining detection systems for rabbit and mouse antibodies, advanced biotin-free polymer systems as well as traditional streptavidin-biotin systems labeled with horseradish peroxidase or alkaline phosphatase.
Unique to the Diagnostic Biosystems offering are antibody cocktails and proprietary chromogens for multicolor staining, focused on improving sensitivity and defining morphology on one tissue section for potentially cancerous cells and/or diagnosis/prognosis. Novel antibodies and multi-stain products include:
DOG-1
Napsin A
OCT4
PermaRed/AP-Auto
PermaBlue/AP
PermaGreen/AP
Stable DAB/
